Actoeside mitigated the renal proximal tubule cells damage triggered by high glucose through miR-766/VCAM1/NF-κB signalling pathway

References

• Adoviča, A., et al., 2017. Deep neck infections: review of 263 cases. Otolaryngologia Polska = the Polish otolaryngology, 71 (5), 37–42.
   PubMedGoogle Scholar
• Bai, Y., et al., 2019. CASC15 contributes to proliferation and invasion through regulating miR-766-5p/KLK12 axis in lung cancer. Cell cycle (Georgetown, TX), 18 (18), 2323–2331.
   PubMed Web of Science ®Google Scholar
• Bell, S., et al., 2015. End-stage renal disease and survival in people with diabetes: a national database linkage study. QJM: monthly journal of the association of physicians, 108 (2), 127–134.
   PubMed Web of Science ®Google Scholar
• Bellah, S.M., et al., 2017. Evaluation of cytotoxic, analgesic, antidiarrheal and phytochemical properties of Hygrophila spinosa (T. Anders) whole plant. Journal of basic and clinical physiology and pharmacology, 28 (2), 185–190.
   PubMedGoogle Scholar
• Branchini, B.R., et al., 2018. A firefly luciferase dual color bioluminescence reporter assay using two substrates to simultaneously monitor two gene expression events. Scientific reports, 8 (1), 5990.
   PubMedGoogle Scholar
• Chen, C.H., et al., 2009. Acteoside and 6-O-acetylacteoside downregulate cell adhesion molecules induced by IL-1beta through inhibition of ERK and JNK in human vascular endothelial cells. Journal of agricultural and food chemistry, 57 (19), 8852–8859.
   PubMed Web of Science ®Google Scholar
• Chen, G.J., et al., 2017a. Retraction statement: ‘Urotensin II inhibits autophagy in renal tubular epithelial cells and induces extracellular matrix production in early diabetic mice’ by Guan‐Jong Chen, Fei Wu, Xin‐Xin Pang, Ai‐Hua Zhang, Jun‐Bao Shi, Min Lu and Chao‐Shu Tang. Journal of diabetes investigation, 8 (4), 629.
   PubMed Web of Science ®Google Scholar
• Chen, L., et al., 2017b. Prediction and analysis of essential genes using the enrichments of gene ontology and KEGG pathways. PloS one., 12 (9), e0184129.
   PubMed Web of Science ®Google Scholar
• Conserva, F., et al., 2019. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of kidney fibrosis in diabetic nephropathy. Scientific reports, 9 (1), 11357.
   PubMedGoogle Scholar
• Davis, A.P., et al., 2021. Comparative Toxicogenomics Database (CTD): update 2021. Nucleic acids research, 49 (D1), D1138–D1143.
   PubMed Web of Science ®Google Scholar
• Elmarakby, A.A., et al., 2012. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovascular Therapeutics, 30 (1), 49–59.
   PubMed Web of Science ®Google Scholar
• Gallo-Oller, G., et al., 2018. A new background subtraction method for Western blot densitometry band quantification through image analysis software. Journal of immunological methods, 457, 1–5.
   PubMed Web of Science ®Google Scholar
• Gan, L., et al., 2018. Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy. Renal failure, 40 (1), 364–370.
   PubMed Web of Science ®Google Scholar
• Guillén-Gómez, E., et al., 2018. Urinary proteome analysis identified neprilysin and VCAM as proteins involved in diabetic nephropathy. Journal of diabetes research, 2018, 6165303.
   PubMed Web of Science ®Google Scholar
• Guo, F., et al., 2018. The interplay of LncRNA ANRIL and miR-181b on the inflammation-relevant coronary artery disease through mediating NF-κB signalling pathway. Journal of cellular and molecular medicine, 22 (10), 5062–5075.
   PubMed Web of Science ®Google Scholar
• Guo, J., et al., 2017. MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin. Scientific reports, 7 (1), 2314.
   PubMed Web of Science ®Google Scholar
• Hayakawa, K., et al., 2019. MicroRNA-766-3p contributes to anti-inflammatory responses through the indirect inhibition of NF-κB signaling. International journal of molecular sciences, 20 (4), 809.
   PubMed Web of Science ®Google Scholar
• He, J., et al., 2011. Advanced research on acteoside for chemistry and bioactivities. Journal of Asian natural products research, 13 (5), 449–464.
   PubMed Web of Science ®Google Scholar
• He, M., et al., 2019. MiR-320a induces diabetic nephropathy via inhibiting MafB. Aging, 11 (10), 3055–3079.
   PubMedGoogle Scholar
• Hsu, J.D., et al., 2016. Myrciaria cauliflora extract improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-nicotinamide mice. Journal of food and drug analysis, 24 (4), 730–737.
   PubMed Web of Science ®Google Scholar
• Ioannou, K., 2017. Diabetic nephropathy: is it always there? Assumptions, weaknesses and pitfalls in the diagnosis. Hormones (Athens, Greece), 16 (4), 351–361.
   PubMedGoogle Scholar
• Jenkin, K.A., et al., 2012. Endocannabinoids and the renal proximal tubule: an emerging role in diabetic nephropathy. The international journal of biochemistry & cell biology, 44 (11), 2028–2031.
   PubMed Web of Science ®Google Scholar
• Jing, W., et al., 2015. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro. Toxicology and applied pharmacology, 285 (2), 128–135.
   PubMed Web of Science ®Google Scholar
• Kato, M., et al., 2014. Diabetic nephropathy – emerging epigenetic mechanisms. Nature reviews nephrology, 10 (9), 517–530.
   PubMed Web of Science ®Google Scholar
• Kong, D.H., et al., 2018. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. International journal of molecular sciences, 19 (4), 1057.
   PubMed Web of Science ®Google Scholar
• Li, M., et al., 2018. Acteoside protects against 6-OHDA-induced dopaminergic neuron damage via Nrf2-ARE signaling pathway. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association, 119, 6–13.
   PubMed Web of Science ®Google Scholar
• Lv, L., et al., 2019. Arbutin protects HK-2 cells against high glucose-induced apoptosis and autophagy by up-regulating microRNA-27a. Artificial cells, nanomedicine, and biotechnology, 47 (1), 2940–2947.
   PubMed Web of Science ®Google Scholar
• Meier, M., et al., 2008. Insulin inhibits caspase-3 activity in human renal tubular epithelial cells via the PI3-kinase/Akt pathway. Cellular physiology and biochemistry, 21 (4), 279–286.
   PubMedGoogle Scholar
• Minami, Y., et al., 2010. Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment. International journal of hematology, 92 (4), 664–666.
   PubMed Web of Science ®Google Scholar
• Nielsen, S., et al., 2002. Aquaporins in the kidney: from molecules to medicine. Physiological reviews, 82 (1), 205–244.
   PubMed Web of Science ®Google Scholar
• Qiao, Z., et al., 2019. Acteoside inhibits inflammatory response via JAK/STAT signaling pathway in osteoarthritic rats. BMC complementary and alternative medicine, 19 (1), 264.
   PubMed Web of Science ®Google Scholar
• Qu, W., et al., 2015. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis. Experimental and clinical endocrinology & diabetes, 123 (06), 353–359.
   PubMedGoogle Scholar
• Rao Kondapally Seshasai, S., et al., 2011. Diabetes mellitus, fasting glucose, and risk of cause-specific death. The New England journal of medicine, 364 (9), 829–841.
   PubMed Web of Science ®Google Scholar
• Reinke, D., et al., 2015. Herbal substance, acteoside, alleviates intestinal mucositis in mice. Gastroenterology research and practice, 2015, 327872.
   PubMed Web of Science ®Google Scholar
• Sedeek, M., et al., 2013. Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of type 2 diabetes. Clinical science, 124 (3), 191–202.
   PubMed Web of Science ®Google Scholar
• Serrero, G., et al., 2018. Measurement of Circulating Progranulin (PGRN/GP88/GEP) by enzyme-linked immunosorbent assay and application in human diseases. Methods in molecular biology (Clifton, NJ), 1806, 95–105.
   PubMedGoogle Scholar
• Sun, Y., et al., 2016. miR-451 suppresses the NF-kappaB-mediated proinflammatory molecules expression through inhibiting LMP7 in diabetic nephropathy. Molecular and cellular endocrinology, 433, 75–86.
   PubMed Web of Science ®Google Scholar
• Tan, G.C.J., et al., 2019. Tocotrienol-rich vitamin E improves diabetic nephropathy and persists 6-9 months after washout: a phase IIa randomized controlled trial. Therapeutic advances in endocrinology and metabolism, 10, 2042018819895462.
   Web of Science ®Google Scholar
• Visekruna, A., et al., 2006. Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis. The journal of clinical investigation, 116 (12), 3195–3203.
   PubMed Web of Science ®Google Scholar
• Wan, R.J., et al., 2018. MicroRNA‑146a/NAPDH oxidase4 decreases reactive oxygen species generation and inflammation in a diabetic nephropathy model. Molecular medicine reports, 17 (3), 4759–4766.
   PubMed Web of Science ®Google Scholar
• Wang, Q., et al., 2017. MiR-766 induces p53 accumulation and G2/M arrest by directly targeting MDM4. Oncotarget, 8 (18), 29914–29924.
   PubMedGoogle Scholar
• Watanabe, N., et al., 2011. Involvement of MAPKs in ICAM-1 expression in glomerular endothelial cells in diabetic nephropathy. Acta medica Okayama, 65 (4), 247–257.
   PubMed Web of Science ®Google Scholar
• Woroniecka, K.I., et al., 2011. Transcriptome analysis of human diabetic kidney disease. Diabetes, 60 (9), 2354–2369.
   PubMed Web of Science ®Google Scholar
• Wu, C., et al., 2015. The function of miR-199a-5p/Klotho regulating TLR4/NF-κB p65/NGAL pathways in rat mesangial cells cultured with high glucose and the mechanism. Molecular and cellular endocrinology, 417, 84–93.
   PubMed Web of Science ®Google Scholar
• Xiong, Y., et al., 2019. The signaling of cellular senescence in diabetic nephropathy. Oxidative medicine and cellular longevity, 2019, 7495629.
   PubMed Web of Science ®Google Scholar
• Yamashita, T., et al., 2012. Fusion of bone marrow-derived cells with renal tubules contributes to renal dysfunction in diabetic nephropathy. FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 26 (4), 1559–1568.
   PubMed Web of Science ®Google Scholar
• Yang, L., et al., 2006. Endothelial cell cortactin coordinates intercellular adhesion molecule-1 clustering and actin cytoskeleton remodeling during polymorphonuclear leukocyte adhesion and transmigration. Journal of immunology (Baltimore, MD: 1950), 177 (9), 6440–6449.
   PubMed Web of Science ®Google Scholar
• Yang, Z.M., et al., 2017. Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population. Molecular medicine reports, 15 (4), 2143–2153.
   PubMed Web of Science ®Google Scholar
• Yi, H., et al., 2017. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell death & disease, 8 (2), e2583.
   PubMedGoogle Scholar
• You, Y., et al., 2018. MicroRNA-766-3p inhibits tumour progression by targeting Wnt3a in hepatocellular carcinoma. Molecules and cells, 41 (9), 830–841.
   PubMed Web of Science ®Google Scholar
• Zhao, M., et al., 2015. Comparative pharmacokinetics of catalpol and acteoside in normal and chronic kidney disease rats after oral administration of Rehmannia glutinosa extract. Biomedical chromatography: BMC, 29 (12), 1842–1848.
   PubMed Web of Science ®Google Scholar
• Zheng, Q., et al., 2015. Effects of Bu Shen Yi Sui Capsule on Th17/Treg cytokines in C57BL/6 mice with experimental autoimmune encephalomyelitis. BMC complementary and alternative medicine, 15 (1), 60.
   PubMedGoogle Scholar